Adjuvant Treatment in Extensive Unilateral Retinoblastoma Primary Enucleated (RB SFCE 2009)

Inclusion criteria

• ✓. Written informed consent - a signed informed consent and/or assent (as age appropriate) will be obtained according to institutional guidelines;
• ✓. Male or female ≥2 months and \<10 years of age at the time of signing the informed consent form;
• ✓. Diagnosis of non familial extensive unilateral retinoblastoma treated by primary enucleation
• ✓. In case of post operative chemotherapy, patients must have adequate organ function:
• ✓. Patients affiliated to a Social Security Regimen or beneficiary of the same
• ✓. No chemotherapy or radiotherapy prior to administration of the first dose of study treatment for retinoblastoma or other tumor types
• ✓. Without medical cons-indication to study drugs.